ロード中...
Tumor Selective Cytotoxic Action of a Thiomorpholin Hydroxamate Inhibitor (TMI-1) in Breast Cancer
BACKGROUND: Targeted therapies, associated with standard chemotherapies, have improved breast cancer care. However, primary and acquired resistances are frequently observed and the development of new concepts is needed. High-throughput approaches to identify new active and safe molecules with or wit...
保存先:
| 主要な著者: | , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Public Library of Science
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3445597/ https://ncbi.nlm.nih.gov/pubmed/23028451 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0043409 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|